2018 American Transplant Congress
De Novo DSA against Third Party Extension Vessels Used in Kidney and Pancreas Transplantation
University of Wisconsin, Madison.
Third party ABO-compatible vessel allografts (VA) are sometimes used as extension vessels for kidney and pancreas transplants (TX). The frequency and implications of de novo…2018 American Transplant Congress
Robotic Pancreas Transplantation in Obese Recipients: Preliminary Results
1Surgery, University of Illinois, Chicago, IL; 2Surgery, University of Virginia, Virginia, VA.
IntroductionObesity is considered a relative contraindication to pancreas transplantation due to increased risks of wound and surgical related complications. Robotic surgery has never been applied…2018 American Transplant Congress
Declining Number of Pancreas after Kidney Transplants Despite Significant Improvement in Outcome
1SUNY Downstate Medical Center, Brooklyn, NY; 2SUNY Upstate Medical University, Syracuse, NY.
Introduction: The number of whole organ pancreas transplants declined significantly over the past 15 years. The largest decrease was seen in pancreas after kidney (PAK)…2018 American Transplant Congress
Morphometric and Metabolic Correlates of Frailty in Pancreas Transplant Recipients
Surgery, Emory University, Atlanta, GA.
Background: Prediction of survival and health resource utilization in the pancreas transplant population requires novel approaches to risk stratification. We studied whether sarcopenia and osteopenia,…2018 American Transplant Congress
Provision of Highly Specialized Aftercare by the Transplant Center Strongly Improves Patient, Pancreas and Kidney Allograft Survival in Long-Term Follow-Up after Simultaneous Pancreas-Kidney Transplantation
Despite rapid medical advancements in the field of transplantation, mean allograft survival remained at a standstill. If and to what extent a highly specialized and…2018 American Transplant Congress
Evolutive Analysis of a 20-Year Pancreas Transplant Program
There is a worldwide trend towards a reduction in the annual number of pancreas transplants (PT). In Brazil, only two centers have performed more than…2018 American Transplant Congress
Experience with Alemtuzumab Induction with Tacrolimus/Mycophenolate +/- Steroids in Simultaneous Pancreas-Kidney Transplant Recipients with Portal-Enteric Drainage
Surgery, Medicine, Pathology, Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC.
Introduction: Simultaneous pancreas-kidney transplant (SPKT) recipients are a relatively homogeneous population that are considered high immunological risk because of younger age, presumed autoimmune etiology of…2018 American Transplant Congress
Rejection and Graft Loss in Patients with BK Viremia after Simultaneous Pancreas and Kidney Transplant
University of Minnesota, Minneapolis, MN.
Background: BK virus is a recognized cause of kidney allograft dysfunction. The treatment of BK is immunosuppression reduction. This reduction in patients with a simultaneous…2018 American Transplant Congress
BK Viremia in Simultaneous Kidney Pancreas Recipients: Single Center Experience
Introduction: The impact of BK viremia in recipients of simultaneous pancreas and kidney transplantation (SPK) is not well known. We therefore studied the incidence and…2018 American Transplant Congress
Impact of New Pancreas Transplant Allocation Policy on Pancreas Transplant Volume and Outcomes: A Single Center Study
BACKGROUND: A UNOS/OPTN policy approved in 2015 allowed simultaneous pancreas-kidney transplants (SPK) for type-2 diabetic patients. We examined the effect of this policy on volume…
American Transplant Congress abstracts